IP Library Granted Patent US 11,981,694
Granted Patent B2
US 11,981,694 · App. 18/147,172 · Granted May 14, 2024

Acyclic thiol prodrugs

Inventors: Manoj Chandrasinhji Desai (Martinez, CA); Siva R. Kamma (Hyderabad, IN)
Assignee: Lilac Therapeutics, Inc.
C07F9/202A61K31/145A61P39/00C07F9/1651C07F9/203
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,981,694
App. No.
18/147,172
Granted
May 14, 2024
Kind
B2
Abstract

Disclosed herein are acyclic thiol prodrugs, and pharmaceutical compositions thereof. The prodrugs and pharmaceutical compositions thereof may be used to treat or prevent medical disorders such as, for example cystinosis, cystinuria, cancer neurodegenerative disease, Parkinson's disease, Huntington's disease, malaria, nonalcoholic fatty liver disease, radiation poisoning, arsenic poisoning, radioprotection, Wilson's disease or rheumatoid arthritis.

Claims (9)

1. A compound of structural formula:

and pharmaceutically acceptable salts, hydrates or solvates thereof.

2. A compound of structural formula:

and pharmaceutically acceptable salts, hydrates or solvates thereof.

3. A compound of structural formula:

and pharmaceutically acceptable salts, hydrates or solvates thereof.

4. A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable vehicle.

5. A pharmaceutical composition comprising the compound of claim 2 and a pharmaceutically acceptable vehicle.

6. A pharmaceutical composition comprising the compound of claim 3 and a pharmaceutically acceptable vehicle.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 18, 2025
From: LILAC THERAPEUTICS, INC.
To: HARP BIO INC.
Reel/Frame 072045/0917 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 11, 2023
From: DESAI, MANOJ CHANDRASINHJI; KAMMA, SIVA R.
To: LILAC THERAPEUTICS, INC.
Reel/Frame 065831/0393 →
Continuity (3)
Provisional Application 63394760 · Aug 3, 2022
Provisional Application 63296052 · Jan 3, 2022
Related Publication 20230212200A1 · Jul 6, 2023